1
2
3
4
5
6
7
8
9
10
11
12
13 | On 12/30/25 at 10:30 am Licensing Program Analyst (LPA) J. Leffall conducted an initial complaint visit to open and to deliver findings on above allegations. LPA met with Resident Care Director (RCD) Britney Polman.
The Department interviewed facility staff, and reviewed resident MAR's. LPA observed from the Assisted Living Med Tech Room R1's medication: Naproxen 500 mg tablet. Take 1 tablet by mouth as needed for pain. Start date is 12/1/25. Per MAR 13 staff initialed as taken sucessfully by R1. Per bubble pack of above medication, 14 tablets were punched out. Per medication count, 1 tablet over was punched out.
Based on observation, record review and interviews conducted, the preponderance of evidence standard has been met, therefore the above allegation is found to be SUBSTANTIATED.
The following deficincies are being cited and civil penalty issued Per Title 22 Regulations.
Exit interview conducted. A copy of this report with appeal rights were distributed to Resident Care Director which confirms signature of this report. |